COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 175 filers reported holding COHERUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,158 | -11.7% | 26,478 | +0.3% | 0.00% | – |
| Q2 2023 | $112,304 | -37.9% | 26,392 | -0.1% | 0.00% | – |
| Q1 2023 | $180,835 | +91.6% | 26,419 | +121.5% | 0.00% | – |
| Q4 2022 | $94,397 | -17.3% | 11,926 | -50.0% | 0.00% | – |
| Q3 2022 | $114,114 | +32.7% | 23,852 | +100.1% | 0.00% | – |
| Q2 2022 | $86,000 | -44.2% | 11,918 | +0.0% | 0.00% | – |
| Q1 2022 | $154,000 | -18.9% | 11,917 | +0.0% | 0.00% | – |
| Q4 2021 | $190,000 | -28.6% | 11,915 | -38.0% | 0.00% | – |
| Q2 2021 | $266,000 | -2.9% | 19,224 | +2.4% | 0.00% | – |
| Q1 2021 | $274,000 | -96.9% | 18,773 | -96.3% | 0.00% | -100.0% |
| Q4 2020 | $8,795,000 | -68.5% | 506,049 | -66.8% | 0.00% | -73.3% |
| Q3 2020 | $27,961,000 | +78.9% | 1,524,587 | +74.2% | 0.02% | +66.7% |
| Q2 2020 | $15,627,000 | – | 874,984 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |